Literature DB >> 28062126

Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection.

Ignacio Correas1, Fernando A Osorio1, David Steffen2, Asit K Pattnaik1, Hiep L X Vu3.   

Abstract

Because porcine reproductive and respiratory syndrome virus (PRRSV) exhibits extensive genetic variation among field isolates, characterizing the extent of cross reactivity of immune responses, and most importantly cell-mediated immunity (CMI), could help in the development of broadly cross-protective vaccines. We infected 12 PRRSV-naïve pigs with PRRSV strain FL12 and determined the number of interferon (IFN)-γ secreting cells (SC) by ELISpot assay using ten type 2 and one type 1 PRRSV isolates as recall antigens. The number of IFN-γ SC was extremely variable among animals, and with exceptions, late to appear. Cross reactivity of IFN-γ SC among type 2 isolates was broad, and we found no evidence of an association between increased genetic distance among isolates and the intensity of the CMI response. Comparable to IFN-γ SC, total antibodies evaluated by indirect immunofluorescence assay (IFA) were cross reactive, however, neutralizing antibody titers could only be detected against the strain used for infection. Finally, we observed a moderate association between homologous IFN-γ SC and neutralizing antibodies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell-mediated immunity; Heterologous immunity; Interferon-γ; Porcine reproductive and respiratory syndrome virus (PRRSV); T cell cross reactivity

Mesh:

Substances:

Year:  2017        PMID: 28062126     DOI: 10.1016/j.vaccine.2016.12.040

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

1.  The Nucleocapsid Protein and Nonstructural Protein 10 of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Enhance CD83 Production via NF-κB and Sp1 Signaling Pathways.

Authors:  Xi Chen; Qiaoya Zhang; Juan Bai; Yongxiang Zhao; Xianwei Wang; Haiyan Wang; Ping Jiang
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

2.  Development of a Monoclonal Antibody to Pig CD69 Reveals Early Activation of T Cells in Pig after PRRSV and ASFV Infection.

Authors:  Yunfei Tian; Yuxin Hao; Maoli Dong; Shuai Li; Dongyue Wang; Fei Jiang; Qingqing Wang; Xiaoli Hao; Yi Yang; Nanhua Chen; Jianzhong Zhu; Junqing Guo; Jiajun Wu; Shaobin Shang; Jiyong Zhou
Journal:  Viruses       Date:  2022-06-20       Impact factor: 5.818

Review 3.  Mechanisms of Adaptive Immunity to Porcine Reproductive and Respiratory Syndrome Virus.

Authors:  Michael C Rahe; Michael P Murtaugh
Journal:  Viruses       Date:  2017-06-13       Impact factor: 5.048

4.  Safety and immune responses after intradermal application of Porcilis PRRS in either the neck or the perianal region.

Authors:  Julia Stadler; Lena Naderer; Lisa Beffort; Mathias Ritzmann; Daniela Emrich; Walter Hermanns; Kerstin Fiebig; Armin Saalmüller; Wilhelm Gerner; Bernadette Glatthaar-Saalmüller; Andrea Ladinig
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

5.  Dynamics and Differences in Systemic and Local Immune Responses After Vaccination With Inactivated and Live Commercial Vaccines and Subsequent Subclinical Infection With PRRS Virus.

Authors:  Miroslav Toman; Vladimir Celer; Lenka Kavanová; Lenka Levá; Jitka Frolichova; Petra Ondráčková; Hana Kudláčková; Kateřina Nechvátalová; Jiri Salat; Martin Faldyna
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

6.  The PRRSV-Specific Memory B Cell Response Is Long-Lived in Blood and Is Boosted During Live Virus Re-exposure.

Authors:  Michael C Rahe; Cheryl M T Dvorak; Abby Patterson; Michael Roof; Michael P Murtaugh
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

7.  Phylogenetic Structure and Sequential Dominance of Sub-Lineages of PRRSV Type-2 Lineage 1 in the United States.

Authors:  Igor A D Paploski; Nakarin Pamornchainavakul; Dennis N Makau; Albert Rovira; Cesar A Corzo; Declan C Schroeder; Maxim C-J Cheeran; Andrea Doeschl-Wilson; Rowland R Kao; Samantha Lycett; Kimberly VanderWaal
Journal:  Vaccines (Basel)       Date:  2021-06-05

Review 8.  Improved Vaccine against PRRSV: Current Progress and Future Perspective.

Authors:  Yuchen Nan; Chunyan Wu; Guoqian Gu; Weiyao Sun; Yan-Jin Zhang; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-08-28       Impact factor: 5.640

9.  Bottlenecks in the transmission of porcine reproductive and respiratory syndrome virus (PRRSV1) to naïve pigs and the quasi-species variation of the virus during infection in vaccinated pigs.

Authors:  Martí Cortey; Gastón Arocena; Emanuela Pileri; Gerard Martín-Valls; Enric Mateu
Journal:  Vet Res       Date:  2018-10-19       Impact factor: 3.683

10.  Efficacy Evaluation of Two Commercial Vaccines Against a Recombinant PRRSV2 Strain ZJnb16-2 From Lineage 8 and 3 in China.

Authors:  Guangwei Han; Huiling Xu; Yanli Wang; Zehui Liu; Fang He
Journal:  Pathogens       Date:  2020-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.